Citigroup
VIVO

Citigroup’s Meridian Bioscience Inc VIVO Stock Holding History

Citigroup’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-54,974
Closed -$1.83M – 6074
2022
Q4 		$1.83M Sell
54,974
-59,079
-52% -$1.9M ﹤0.01% 2114
2022
Q3 		$3.6M Buy
114,053
+88,644
+349% +$2.87M ﹤0.01% 1742
2022
Q2 		$773K Sell
25,409
-23,426
-48% -$634K ﹤0.01% 2881
2022
Q1 		$1.27M Buy
48,835
+1,200
+3% +$28.5K ﹤0.01% 2735
2021
Q4 		$972K Buy
47,635
+22,741
+91% +$436K ﹤0.01% 3294
2021
Q3 		$479K Buy
24,894
+691
+3% +$13.8K ﹤0.01% 3647
2021
Q2 		$537K Buy
24,203
+18,779
+346% +$398K ﹤0.01% 3659
2021
Q1 		$142K Sell
5,424
-24,807
-82% -$590K ﹤0.01% 4205
2020
Q4 		$565K Buy
30,231
+1,830
+6% +$34.2K ﹤0.01% 4093
2020
Q3 		$482K Buy
28,401
+1,948
+7% +$37.9K ﹤0.01% 3875
2020
Q2 		$616K Buy
26,453
+12,414
+88% +$180K ﹤0.01% 4047
2020
Q1 		$118K Sell
14,039
-5,730
-29% -$48.2K ﹤0.01% 5208
2019
Q4 		$193K Sell
19,769
-6,949
-26% -$65.2K ﹤0.01% 5222
2019
Q3 		$254K Sell
26,718
-4,590
-15% -$48.4K ﹤0.01% 4945
2019
Q2 		$372K Buy
31,308
+6,410
+26% +$77.2K ﹤0.01% 4717
2019
Q1 		$438K Sell
24,898
-4,490
-15% -$74.7K ﹤0.01% 4327
2018
Q4 		$510K Sell
29,388
-764
-3% -$13K ﹤0.01% 4111
2018
Q3 		$449K Sell
30,152
-29,784
-50% -$462K ﹤0.01% 4415
2018
Q2 		$953K Sell
59,936
-19,285
-24% -$288K ﹤0.01% 3413
2018
Q1 		$1.13M Buy
79,221
+3,471
+5% +$51.4K ﹤0.01% 3133
2017
Q4 		$1.06M Sell
75,750
-19,187
-20% -$281K ﹤0.01% 3283
2017
Q3 		$1.36M Sell
94,937
-8,485
-8% -$121K ﹤0.01% 3056
2017
Q2 		$1.63M Sell
103,422
-3,039
-3% -$43.8K ﹤0.01% 2799
2017
Q1 		$1.47M Sell
106,461
-27,772
-21% -$388K ﹤0.01% 2794
2016
Q4 		$2.38M Buy
134,233
+49,587
+59% +$871K ﹤0.01% 2731
2016
Q3 		$1.63M Buy
84,646
+31,479
+59% +$616K ﹤0.01% 2712
2016
Q2 		$1.04M Buy
53,167
+22,893
+76% +$449K ﹤0.01% 2922
2016
Q1 		$624K Buy
30,274
+29,261
+2,889% +$577K ﹤0.01% 3883
2015
Q4 		$21K Sell
1,013
-1,343
-57% -$25.7K ﹤0.01% 6466
2015
Q3 		$40K Sell
2,356
-3,180
-57% -$58.1K ﹤0.01% 5589
2015
Q2 		$103K Buy
5,536
+3,268
+144% +$60.6K ﹤0.01% 4969
2015
Q1 		$43K Buy
2,268
+408
+22% +$7.54K ﹤0.01% 5622
2014
Q4 		$31K Sell
1,860
-1,268
-41% -$21.8K ﹤0.01% 5993
2014
Q3 		$56K Sell
3,128
-2,971
-49% -$58.4K ﹤0.01% 5236
2014
Q2 		$126K Buy
6,099
+4,069
+200% +$83.6K ﹤0.01% 4506
2014
Q1 		$45K Buy
2,030
+1,988
+4,733% +$45.6K ﹤0.01% 5553
2013
Q4 		$1K Sell
42
-402
-91% -$9.88K ﹤0.01% 6892
2013
Q3 		$10K Sell
444
-102
-19% -$2.38K ﹤0.01% 6218
2013
Q2 		$12K Buy
+546
New +$11.8K ﹤0.01% 6041

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's VIVO Position: Q1 2023 in Review

Citigroup sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 54,974 shares — an estimated $1.83M sold.

Citigroup first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $3.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Citigroup reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 54,974 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.83M.
  • Citigroup first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Citigroup's Meridian Bioscience Inc position peaked at $3.6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.